Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SNARE proteins (soluble NSF attachment protein receptors) are a large superfamily of membrane-associated proteins essential for mediating the fusion of transport vesicles with their target membranes, including the plasma membrane and other cell compartments[1][3][6]. They are central components of the membrane trafficking machinery and play a vital role in exocytosis, endocytosis, and the regulated release of neurotransmitters and hormones[2][3]. SNARE proteins can be classified into v-SNAREs (vesicle-associated, such as synaptobrevin/VAMP) and t-SNAREs (target membrane-associated, such as syntaxin and SNAP-25), but are now more accurately divided by their conserved sequence motifs into R-SNAREs and Q-SNAREs, according to which residue (arginine or glutamine) they contribute to the central SNARE complex[1][4][5][6]. A functional SNARE complex mediating membrane fusion typically forms a four-helix bundle consisting of one R-SNARE and three Q-SNAREs (Qa, Qb, and Qc)[1][6]. SNARE protein assembly brings vesicular and target membranes into close proximity, driving membrane fusion via the energy released from complex formation[2][3]. SNAREs are involved in many biological functions including synaptic vesicle fusion (neurotransmitter release), hormone secretion, and general intracellular vesicle trafficking[1][2][5]. Dysfunction or targeting of SNAREs (e.g., by botulinum or tetanus toxins) can lead to severe disorders, such as paralysis or neurodegenerative conditions[1][5]. The SNARE complex is a direct target of potent neurotoxins, which cleave one or more SNARE proteins, thereby impairing neurotransmitter release[1][5]. There are more than 60 SNARE isoforms in mammals, reflecting their participation in distinct membrane trafficking routes and their specificity across cell types and compartments[1][3][6]. SNAREs interact with various regulators (e.g., Munc18, complexin) and membrane lipids, further tuning their function in membrane fusion[2]. SNARE proteins are considered validated–and essential–therapeutic targets in the context of specific neurotoxins, but generally their broad and critical cellular roles limit safe pharmacological targeting[1].
Inhibition of SNARE-mediated vesicle fusion (by neurotoxins), Disruption of neurotransmitter/hormone release
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SNARE protein (SNARE).